Notice: Prescription Drug List (PDL): Multiple Additions (2021-07-23)

The purpose of this Notice of Amendment is to notify about the additions of the following medicinal ingredients on the Prescription Drug List (PDL) for human and veterinary use: Brexucabtagene autoleucel; Idecabtagene vicleucel; Pitolisant; Risdiplam; Selpercatinib; Solriamfetol; Tepotinib; Tildrakizumab; Trastuzumab; deruxtecan.

Data and Resources

Additional Info

Field Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Avis : Liste des drogues sur ordonnance (LDO) : additions multiples (2021-07-23)
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published 2021-07-19 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["avis de modification", "Liste des drogues sur ordonnance", "LPD", "ingrédients médicinaux", "usage humain et vétérinaire", "Brexucabtagene autoleucel", "Idecabtagene vicleucel", "Pitolisant", "Risdiplam", "Selpercatinib", "Solriamfetol", "Tepotinib", "Tildrakizumab", "Trastuzumab", "deruxtecan"], "en": ["notice of amendment", "Prescription Drug List", "PDL", "medicinal ingredients", "human-and-veterinary use", "Brexucabtagene autoleucel", "Idecabtagene vicleucel", "Pitolisant", "Risdiplam", "Selpercatinib", "Solriamfetol", "Tepotinib", "Tildrakizumab", "Trastuzumab", "deruxtecan"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source